Tilray Medical, a division of cannabis powerhouse Tilray Brands (TSX:TLRY), has partnered with Molteni, a top Italian pharmaceutical firm focused on pain therapies and substance dependence, to broaden the availability of its cannabis extracts across Italy. Under the partnership, Tilray Medical subsidiary, FL Group, will provide medical cannabis education throughout Molteni’s network of pharmaceutical, scientific and medical professionals in Italy.
Click here for the full story.
Weekly Update – Top Cannabis News Stories
1 | MediPharm lays out the implications for possible new U.S. cannabis rescheduling
2 | Canopy Growth, Silver North Resources, Vonovia – Clear signals
3 | Aurora Cannabis: Profitability plus falling stock equals value play
4 | Three commodity stocks to strengthen inflation protection
Top Cannabis Stocks Aug. 8 to Aug. 14, 2025
1. T.TLRY | 10,556 views | Tilray Brands Inc.
2. T.LABS | 6,710 views | Medipharm Labs Corp.
3. T.CURA | 6,665 views | Curaleaf Holdings Inc.
4. T.WEED | 6,076 views | Canopy Growth Corp.
5. T.OGI | 1,4750 views | Organigram Holdings Inc.
6. T.ACB | 911 views | Aurora Cannabis Inc.
Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.
